Beximco Pharmaceuticals (LON:BXP) Hits New 1-Year Low at $31.03

Shares of Beximco Pharmaceuticals Limited (LON:BXP) hit a new 52-week low on Wednesday . The stock traded as low as GBX 31.03 ($0.40) and last traded at GBX 34 ($0.44), with a volume of 94197 shares. The stock had previously closed at GBX 33 ($0.43).

Beximco Pharmaceuticals Stock Performance

The company has a quick ratio of 0.37, a current ratio of 1.80 and a debt-to-equity ratio of 14.73. The firm has a market cap of £151.68 million, a P/E ratio of 425.00 and a beta of 0.64. The business has a fifty day simple moving average of GBX 38.03 and a 200-day simple moving average of GBX 38.47.

Beximco Pharmaceuticals Company Profile

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.